Literature DB >> 23937199

Transient blood brain barrier disruption induced by oleic acid is mediated by nitric oxide.

Hyung Soo Han1, Jae Hee Jang, Jae Sik Park, Hak Jin Kim, Jong Kun Kim.   

Abstract

The blood brain barrier (BBB) maintains cerebral microenvironmental homeostasis. Transient disruption of the BBB after brain fat embolism in clinical cases and animal models has been reported but the precise mechanism underlying this occurrence is unclear. In the present study, we investigated BBB alterations in rats treated oleic acid (OA) delivered intra-arterially. Following OA treatment, transient brain edema, extravasation of Evans blue and Fluorescein isothiocyanate (FITC)-labeled dextran, and loss of laminin in the affected brain area were observed. Activation of matrix metalloproteinase (MMP)-2, -3, and -13 was found in the cerebral vessels 2 h after OA administration. Expression of intercellular adhesion molecule (ICAM)-1 in the vessels and neutrophil infiltration into the brain tissue was also observed. Inducible nitric oxide synthase (iNOS) was expressed in the neutrophils and nitrotyrosine was produced mainly in the vessels. Inhibitor of iNOS activity suppressed the loss of laminin, leakage of FITC-labeled dextran and Evans blue, and activation of MMP-2 and -13. Protein level of aquaporin (AQ)-4 was increased after OA administration but was not affected by treatment with iNOS inhibitor. In conclusion, we suggest that nitric oxide (NO) contributes to OA-induced MMP activation, BBB disruption and the development of transient brain edema.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23937199     DOI: 10.2174/15672026113109990024

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  5 in total

1.  Fat embolism syndrome after femur fracture fixation: a case report.

Authors:  Craig C Akoh; Cameron Schick; Jesse Otero; Matthew Karam
Journal:  Iowa Orthop J       Date:  2014

2.  The minimum percentage of triolein emulsion for studying cerebral vascular permeability with least brain edema.

Authors:  Seon Hee Choi; Hak Jin Kim; Lee Hwangbo; Yong-Woo Kim
Journal:  Iran J Radiol       Date:  2014-09-23       Impact factor: 0.212

3.  Metabolomic Profiling of Brain Protective Effect of Edaravone on Cerebral Ischemia-Reperfusion Injury in Mice.

Authors:  Hui-Fen Ma; Fan Zheng; Lin-Jie Su; Da-Wei Zhang; Yi-Ning Liu; Fang Li; Yuan-Yuan Zhang; Shuai-Shuai Gong; Jun-Ping Kou
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

4.  Plasma Lipolysis and Changes in Plasma and Cerebrospinal Fluid Signaling Lipids Reveal Abnormal Lipid Metabolism in Chronic Migraine.

Authors:  Katherine Castor; Jessica Dawlaty; Xianghong Arakaki; Noah Gross; Yohannes W Woldeamanuel; Michael G Harrington; Robert P Cowan; Alfred N Fonteh
Journal:  Front Mol Neurosci       Date:  2021-08-31       Impact factor: 5.639

5.  Influence of rosuvastatin treatment on cerebral inflammation and nitro-oxidative stress in experimental lung injury in pigs.

Authors:  Jens Kamuf; Andreas Garcia Bardon; Alexander Ziebart; Robert Ruemmler; Johannes Schwab; Mobin Dib; Andreas Daiber; Serge C Thal; Erik K Hartmann
Journal:  BMC Anesthesiol       Date:  2021-09-13       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.